A chimaeric llβ-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Glucocorticoid-remediable aldosteronism (GRA), an autosomal dominant disorder, is characterized by hypertension with variable hyperaldosteronism and by high levels of the abnormal adrenal steroids 18-oxocortisol and 18-hydroxycortisol, which are all under control of adrenocorticotropic hormone and suppressible by glucocorticoids. These abnormalities could result from ectopic expression of aldosterone synthase, which is normally expressed only in adrenal glomerulosa, in the adrenal fasciculata. Genes encoding aldosterone synthase and steroid 11 beta-hydroxylase (expressed in both adrenal fasciculata and glomerulosa), which are 95% identical and lie on chromosome 8q (refs 7, 10), are therefore candidate genes for GRA. Here we demonstrate complete linkage of GRA in a large kindred to a gene duplication arising from unequal crossing over, fusing the 5' regulatory region of 11 beta-hydroxylase to the coding sequences of aldosterone synthase (maximum lod score 5.23 for complete linkage, odds ratio of 170,000:1). This mutation can account for all the physiological abnormalities of GRA. Our result represents the demonstration of a mutation causing hypertension in otherwise phenotypically normal animals or humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consistent with a tandem duplication event, the two human genes are closely linked, separated by 40 kb, exhibiting similar intron/exon structure, and 90 and 95% identity in the coding and non-coding sequences, respectively (59, 70).”
From Adrenal Mitochondria and Steroidogenesis: From Individual Proteins to Functional Protein Assemblies (2016) · cites this paper as [70]
In the citing paper
“Although gene conversion events in the CYP11B locus are rare, an unusual gene duplication, caused by unequal crossing over between the CYP11B1 and CYP11B2 genes, results in glucocorticoid-remediable aldosteronism (GRA) (490 -492).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [490]
In the citing paper
“The crossover results in one allele having a third, hybrid CYP11B gene in which the ACTHregulated promoter and the first few exons of CYP11B1 are fused in frame to most of the exons of CYP11B2, resulting in the zona fasciculata expression of a chimeric protein with aldosterone synthase activity (490, 491) (Fig. 12).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [490]
In the citing paper
“They are particularly important in patients in glucocorticoid remediable aldosteronism or with aldosterone-producing adenomas associated with KCNJ5 mutations [261,[264], [265], [266], [267], [268], [269], [270], [271], [272]].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [264]
In the citing paper
“Urinary excretion of aldosterone metabolites is increased (Fig. 6) (115, 124), with the urinary (18OHF+18oxoF)/THAldo ratio further supporting diagnosis (116); the urinary metabolite 18oxoTHF (Fig. 7) is characteristically increased.”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [124]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,887
Orita, M., Suzuki, Y., Sekiya, T., & Hayashi, K. (1989) · Genomics · doi:10.1016/0888-7543(89)90129-8 · Cited by 3,434
Hypertension : pathophysiology, diagnosis, and management
Laragh, J. H., & Brenner, B. M. (1995) · Raven Press eBooks · Cited by 1,932
Gilliland, G., Perrin, S., Blanchard, K., & Bunn, H. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.7.2725 · Cited by 1,454
Hypertension: Pathophysiology, Diagnosis, and Management
White, W. B. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460110128039 · Cited by 944
Polymorphic DNA region adjacent to the 5' end of the human insulin gene.
Bell, G. I., Karam, J. H., & Rutter, W. J. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.9.5759 · Cited by 889
Regulation of the synthesis of steroidogenic enzymes in adrenal cortical cells by ACTH
Simpson, E. R., & Waterman, M. R. (1988) · Annual Review of Physiology · doi:10.1146/annurev.ph.50.030188.002235 · Cited by 506
Sutherland, D. J., Ruse, J. L., & Laidlaw, J. C. (1966) · PubMed Central · Cited by 467
Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta).
Mornet, É., Dupont, J., Vitek, A., & White, P. C. (1989) · PubMed · Cited by 440
Characterization of Two Genes Encoding Human Steroid 11β-Hydroxylase (P-45011β)
Mornet, E., Dupont, J., Vitek, A., & White, P. C. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)30030-4 · Cited by 405
Research works printed but not linked: 2
- Sutherland, D. J., Ruse, J. L. & Laidlaw, J. C. Can. med. Assoc. J. 95, 1109–1119 (1966).
- Pickering, G. W. in The Epidemiology of Hypertension (eds Stamler, J., Stamler, R. & Pullman, T. N.) 18–27 (Grune & Stratton, New York, 1967).
Cited by
Items 101–200 of 995
Genome Duplications and Other Features in 12 Mb of DNA Sequence from Human Chromosome 16p and 16q
Loftus, B., Kim, U.-J., Sneddon, V. P., Kalush, F., Brandon, R. C., Fuhrmann, J. L., Mason, T. M., Crosby, M., Barnstead, M., Cronin, L. A., et al. (1999) · Genomics · doi:10.1006/geno.1999.5927 · Cited by 148
Guengerich, F. P. (2015) · Springer eBooks · doi:10.1007/978-3-319-12108-6_9 · Cited by 214
STEROID 11β-HYDROXYLASE DEFICIENCY AND RELATED DISORDERS
White, P. C. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(08)70019-7 · Cited by 153
Bassett, M., Zhang, Y., Clyne, C., White, P., & Rainey, W. (2002) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0280125 · Cited by 146
Molecular Genetics of Human Hypertension: Role of Angiotensinogen
Corvol, P. L., & Jeunemaître, X. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.5.0312 · Cited by 166
Cicila, G. T., Rapp, J. P., Wang, J.-M., Lezin, E. S., Ng, S. C., & Kurtz, T. W. (1993) · Nature Genetics · doi:10.1038/ng0493-346 · Cited by 145
Heterogeneous responses to changes in dietary salt intake: the salt-sensitivity paradigm
Luft, F. C., & Weinberger, M. H. (1997) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.2.612s · Cited by 141
Schuster, H., Wienker, T. F., Bähring, S., Bilginturan, N., Toka, H. R., Neitzel, H., Jeschke, E., Toka, O., Gilbert, D. A., Lowe, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0596-98 · Cited by 143
Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism
Storbeck, K.-H., Schiffer, L., Baranowski, E. S., Chortis, V., Prete, A., Barnard, L., Gilligan, L. C., Taylor, A. E., Idkowiak, J., Arlt, W., et al. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00262 · Cited by 141
Genetics of Ischemic Stroke, Stroke-Related Risk Factors, Stroke Precursors and Treatments
Della‐Morte, D., Guadagni, F., Palmirotta, R., Testa, G., Caso, V., Paciaroni, M., Abete, P., Rengo, F., Ferroni, P., Sacco, R. L., et al. (2012) · Pharmacogenomics · doi:10.2217/pgs.12.14 · Cited by 147
Gordon, R. D. (1995) · Journal of Endocrinological Investigation · doi:10.1007/bf03349761 · Cited by 158
Rossi, G. P., Bisogni, V., Bacca, A., Belfiore, A., Cesari, M., Concistrè, A., Pinto, R. D., Fabris, B., Fallo, F., Fava, C., et al. (2020) · International Journal of Cardiology Hypertension · doi:10.1016/j.ijchy.2020.100029 · Cited by 147
Corvol, P. L., Persu, A., Gimenez‐Roqueplo, A., & Jeunemaître, X. (1999) · Hypertension · doi:10.1161/01.hyp.33.6.1324 · Cited by 151
MECHANISMS IN ENDOCRINOLOGY: Rare defects in adrenal steroidogenesis
Miller, W. L. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0279 · Cited by 136
Structural Insights into Aldosterone Synthase Substrate Specificity and Targeted Inhibition
Strushkevich, N., Gilep, A. A., Shen, L., Arrowsmith, C. H., Edwards, A. M., Usanov, S. A., & Park, H.-W. (2013) · Molecular Endocrinology · doi:10.1210/me.2012-1287 · Cited by 135
Pascoe, L., Jeunemaitre, X., Lebrethon, M. C., Curnow, K. M., Gomez-Sanchez, C. E., Gasc, J. M., Saez, J. M., & Corvol, P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118279 · Cited by 137
Molecular genetics of human hypertension
Luft, F. C. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816121-00004 · Cited by 133
Aldosterone synthase deficiency and related disorders
White, P. C. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.013 · Cited by 140
Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27
Lee, M. A., Bohm, M., Paul, M., Bader, M., Ganten, U., & Ganten, D. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.270.6.e919 · Cited by 132
Primary Aldosteronism: State-of-the-Art Review
Vaidya, A., Hundemer, G. L., Nanba, K., Parksook, W. W., & Brown, J. M. (2022) · American Journal of Hypertension · doi:10.1093/ajh/hpac079 · Cited by 150
Aldosterone- and cortisol-co-secreting adrenal tumors: the lost subtype of primary aldosteronism
Späth, M. R., Korovkin, S., Antke, C., Anlauf, M., & Willenberg, H. S. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1070 · Cited by 137
Satoh, F., Morimoto, R., Ono, Y., Iwakura, Y., Omata, K., Kudo, M., Takase, K., Seiji, K., Sasamoto, H., Honma, S., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.04453 · Cited by 129
Clinical applications of gas chromatography and gas chromatography–mass spectrometry of steroids
Wolthers, B. G., & Kraan, G. P. B. (1999) · Journal of Chromatography A · doi:10.1016/s0021-9673(99)00153-3 · Cited by 143
Williams, T. A., & Reincke, M. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0990 · Cited by 141
Glucocorticoid-Remediable Aldosteronism
McMahon, G. T., & Dluhy, R. G. (2004) · Cardiology in Review · doi:10.1097/01.crd.0000096417.42861.ce · Cited by 130
Self-citationGenetic variations related to hypertension: a review
Tanira, M. O. M., & Al-Balushi, K. (2004) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001780 · Cited by 137
Mulatero, P., Veglio, F., Pilon, C., Rabbia, F., Zocchi, C., Limone, P. P., Boscaro, M., Sonino, N., & Fallo, F. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.7.2573 · Cited by 126
Conference Report on Stroke Mortality in the Southeastern United States
Perry, H. M., & Roccella, E. J. (1998) · Hypertension · doi:10.1161/01.hyp.31.6.1206 · Cited by 125
Kim, H., Lee, G. T., John, S. W. M., Maeda, N., & Smithies, O. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072083799 · Cited by 125
Takami, S., Katsuya, T., Rakugi, H., Sato, N., Nakata, Y., Kamitani, A., Miki, T., Higaki, J., & Ogihara, T. (1998) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00457-3 · Cited by 126
Genetics of essential hypertension
Kurtz, T. W., & Spence, M. A. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90124-8 · Cited by 123
Role of KCNJ5 in familial and sporadic primary aldosteronism
Mulatero, P., Monticone, S., Rainey, W. E., Veglio, F., & Williams, T. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.230 · Cited by 133
6 Mineralocorticoid resistance
Komesaroff, P. A., Funder, J. W., & Fuller, P. J. (1994) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80256-3 · Cited by 123
Fogari, R., Preti, P. S., Zoppi, A., Rinaldi, A., Fogari, E., & Mugellini, A. (2007) · Hypertension Research · doi:10.1291/hypres.30.111 · Cited by 134
Mechanisms of Hypertension: The Expanding Role of Aldosterone
Freel, E. M., & Connell, J. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000132473.50966.14 · Cited by 144
Genetics of Primary Aldosteronism
Scholl, U. I. (2022) · Hypertension · doi:10.1161/hypertensionaha.121.16498 · Cited by 153
Adrenal Mitochondria and Steroidogenesis: From Individual Proteins to Functional Protein Assemblies
Midzak, A., & Papadopoulos, V. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00106 · Cited by 114
“Consistent with a tandem duplication event, the two human genes are closely linked, separated by 40 kb, exhibiting similar intron/exon structure, and 90 and 95% identity in the coding and non-coding sequences, respectively (59, 70).”
BackgroundA review of the genetics of essential hypertension
Binder, A. (2007) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3280d357f9 · Cited by 125
Advances in Blood Pressure Genomics
Munroe, P. B., Barnes, M. R., & Caulfield, M. J. (2013) · Circulation Research · doi:10.1161/circresaha.112.300387 · Cited by 112
Padmanabhan, S., & Joe, B. (2017) · Physiological Reviews · doi:10.1152/physrev.00035.2016 · Cited by 130
Low-Renin Hypertension, Altered Sodium Homeostasis, and an α-Adducin Polymorphism
Grant, F. D., Romero, J. R., Jeunemaı̂tre, X., Hunt, S. C., Hopkins, P. N., Hollenberg, N. K., & Williams, G. H. (2002) · Hypertension · doi:10.1161/hy0202.104273 · Cited by 108
Pathological Consequences of Sequence Duplications in the Human Genome
Mazzarella, R., & Schlessinger, D. (1998) · Genome Research · doi:10.1101/gr.8.10.1007 · Cited by 109
Omics of Blood Pressure and Hypertension
Arnett, D. K., & Claas, S. A. (2018) · Circulation Research · doi:10.1161/circresaha.118.311342 · Cited by 114
Liddle Syndrome: Genetics and Mechanisms of Na+ Channel Defects
Warnock, D. G. (2001) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200112000-00002 · Cited by 115
Recombination Hot Spots and Human Disease
Purandare, S. M., & Patel, P. I. (1997) · Genome Research · doi:10.1101/gr.7.8.773 · Cited by 123
Hypertension: genes versus environment
Harrap, S. B. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92762-6 · Cited by 106
Activating Mutation of the Renal Epithelial Chloride Channel ClC-Kb Predisposing to Hypertension
Jeck, N., Waldegger, S., Lampert, A., Boehmer, C., Waldegger, P., Lang, P. A., Wissinger, B., Friedrich, B., Risler, T., Moehle, R., et al. (2004) · Hypertension · doi:10.1161/01.hyp.0000129824.12959.f0 · Cited by 106
Primary hyperaldosteronism, a mediator of progressive renal disease in cats
Javadi, S., Djajadiningrat‐Laanen, S. C., Kooistra, H. S., van Dongen, A. M., Voorhout, G., van Sluijs, F. J., van den Ingh, T. S. G. A. M., Boer, W. H., & Rijnberk, A. (2004) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2004.06.010 · Cited by 122
Heritable forms of hypertension
Vehaskari, V. M. (2007) · Pediatric Nephrology · doi:10.1007/s00467-007-0537-8 · Cited by 117
Curnow, K. M., Mulatero, P., Emeric-Blanchouin, N., Aupetit-Faisant, B., Corvol, P., & Pascoe, L. (1997) · Nature Structural & Molecular Biology · doi:10.1038/nsb0197-32 · Cited by 102
Piaditis, G. P., Markou, Α., Papanastasiou, L., Androulakis, I. I., & Kaltsas, G. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0537 · Cited by 105
Adaptation, allometry, and hypertension.
Weder, A. B., & Schork, N. J. (1994) · Hypertension · doi:10.1161/01.hyp.24.2.145 · Cited by 99
Genomic map of cardiovascular phenotypes of hypertension in female Dahl S rats
Moreno, C., Dumas, P., Kaldunski, M. L., Tonellato, P. J., Greene, A. S., Roman, R. J., Cheng, Q., Wang, Z., Jacob, H. J., & Cowley, A. W. (2003) · Physiological Genomics · doi:10.1152/physiolgenomics.00105.2003 · Cited by 105
Primary aldosteronism: hypertension with a genetic basis
Gordon, R. D., Klemm, S. A., Tunny, T. J., & Stowasser, M. (1992) · The Lancet · doi:10.1016/0140-6736(92)93225-c · Cited by 99
Intrarenal Transport and Vasoactive Substances in Hypertension
Ortiz, P. A., & Garvin, J. L. (2001) · Hypertension · doi:10.1161/hy09t1.093361 · Cited by 104
Mineralocorticoid hypertension
Gordon, R. D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)93003-1 · Cited by 99
Genetic Causes of Functional Adrenocortical Adenomas
Zennaro, M., Boulkroun, S., & Fernandes-Rosa, F. L. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00189 · Cited by 109
Modulation of aldosterone and cortisol synthesis on the molecular level
Lisurek, M., & Bernhardt, R. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.11.008 · Cited by 116
Genetics of Congenital Adrenal Hyperplasia
Hannah-Shmouni, F., Chen, W., & Merke, D. P. (2017) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.01.008 · Cited by 97
Abnormal regulation of ENaC: syndromes of salt retention and salt wasting by the collecting duct
Schafer, J. A. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00068.2002 · Cited by 104
So, A., Duffy, D. L., Gordon, R. D., Jeske, Y. W., Lin-Su, K., New, M. I., & Stowasser, M. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000174299.66369.26 · Cited by 98
Diagnosis and treatment of low‐renin hypertension
Mulatero, P., Verhovez, A., Morello, F., & Veglio, F. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02898.x · Cited by 111
Glucocorticoid-remediable aldosteronism is associated with severe hypertension in early childhood
Dluhy, R. G., Anderson, B. F., Harlin, B., Ingelfinger, J. R., & Lifton, R. P. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.112648 · Cited by 96
Self-citationEpidemiology of Risk Factors for Hypertension: Implications for Prevention and Therapy
Kornitzer, M., Dramaix, M., & Backer, G. D. (1999) · Drugs · doi:10.2165/00003495-199957050-00003 · Cited by 112
Increased Urinary Free Cortisol: A Potential Intermediate Phenotype of Essential Hypertension
Litchfield, W. R., Hunt, S. C., Jeunemaitre, X., Fisher, N. D. L., Hopkins, P. N., Williams, R. R., Corvol, P., & Williams, G. H. (1998) · Hypertension · doi:10.1161/01.hyp.31.2.569 · Cited by 96
Genomewide Linkage Scan of Resting Blood Pressure: HERITAGE Family Study
Rice, T., Rankinen, T., Chagnon, Y. C., Province, M. A., Përusse, L., Leon, A. S., Skinner, J. S., Wilmore, J. H., Bouchard, C., & Rao, D. C. (2002) · Hypertension · doi:10.1161/01.hyp.0000018911.46067.6e · Cited by 105
Stowasser, M., Bachmann, A. W., Huggard, P. R., Rossetti, T. R., & Gordon, R. D. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6834 · Cited by 97
Stowasser, M., & Gordon, R. D. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00097-8 · Cited by 101
Samani, N. J., Lodwick, D., Vincent, M., Dubay, C., Kaiser, M., Kelly, M. P., Lo, M., Harris, J., Sassard, J., & Lathrop, M. G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116616 · Cited by 93
Genetics of essential hypertension
Mein, C. A., Caulfield, M. J., Dobson, R. J., & Munroe, P. B. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh078 · Cited by 93
CYP17- and CYP11B-dependent steroid hydroxylases as drug development targets
Hakki, T., & Bernhardt, R. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.07.006 · Cited by 98
$alpha;2-Adrenergic Receptor Gene Polymorphism and Hypertension in Blacks
Lockette, W. E., Ghosh, S., Farrow, S., MacKenzie, S., Baker, S., Miles, P., Schork, A., & Cadaret, L. (1995) · American Journal of Hypertension · doi:10.1016/0895-7061(95)00024-j · Cited by 90
Laboratory challenges in primary aldosteronism screening and diagnosis
Rehan, M., Raizman, J. E., Cavalier, E., Don-Wauchope, A. C., & Holmes, D. T. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2015.01.003 · Cited by 89
PHEOCHROMOCYTOMA AND PRIMARY ALDOSTERONISM: DIAGNOSTIC APPROACHES
Young, W. F. (1997) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70283-8 · Cited by 89
Mulatero, P., Curnow, K. M., Aupetit-Faisant, B., Foekling, M., Gomez-Sanchez, C., Veglio, F., Jeunemaitre, X., Corvol, P., & Pascoe, L. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.11.5237 · Cited by 88
Primary aldosteronism: Are we diagnosing and operating on too few patients?
Gordon, R. D., Stowasser, M., & Rutherford, J. C. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0033-4 · Cited by 88
The Human Steroid Hydroxylases CYP11B1 and CYP11B2
Bureik, M., Lisurek, M., & Bernhardt, R. (2002) · Biological Chemistry · doi:10.1515/bc.2002.174 · Cited by 87
Sukor, N., Mulatero, P., Gordon, R. D., So, A., Duffy, D. L., Bertello, C., Kelemen, L., Jeske, Y. W. A., Veglio, F., & Stowasser, M. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283028352 · Cited by 88
Diagnosis and management of primary aldosteronism
Vilela, L. A. P., & Almeida, M. Q. (2017) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000274 · Cited by 101
The Y Chromosome Effect on Blood Pressure in Two European Populations
Charchar, F. J., Tomaszewski, M., Padmanabhan, S., Łacka, B., Upton, M. N., Inglis, G. C., Anderson, N., McConnachie, A., Zukowska-Szczechowska, E., Grzeszczak, W., et al. (2002) · Hypertension · doi:10.1161/hy0202.103413 · Cited by 88
Glucocorticoid-dependent hypertension
Mantero, F., & Boscaro, M. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90077-v · Cited by 96
Primary Aldosteronism: Management Issues
Young, W. F. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04413.x · Cited by 98
Melander, O., Orho‐Melander, M., Bengtsson, K., Lindblad, U., Råstam, L., Groop, L., & Hulthén, U. L. (2000) · Hypertension · doi:10.1161/01.hyp.36.3.389 · Cited by 92
Litchfield, W. R., New, M. I., Coolidge, C., Lifton, R. P., & Dluhy, R. G. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4381 · Cited by 84
Self-citationInherited Forms of Mineralocorticoid Hypertension
White, P. C. (1996) · Hypertension · doi:10.1161/01.hyp.28.6.927 · Cited by 92
A Genome-Wide Search For Susceptibility Loci to Human Essential Hypertension
Sharma, P., Fatibene, J., Ferraro, F., Jia, H., Monteith, S., Brown, C. C., Clayton, D. G., O’Shaughnessy, K. M., & Brown, M. J. (2000) · Hypertension · doi:10.1161/01.hyp.35.6.1291 · Cited by 95
Molecular genetics of essential hypertension
Singh, M., Singh, A., Pandey, P., Chandra, S., Singh, K. A., & Gambhir, I. S. (2016) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2015.1116543 · Cited by 104
General overview of mineralocorticoid hormone action
Agarwal, M. K., & Mirshahi, M. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00038-8 · Cited by 99
Chandra, S., Narang, R., Sreenivas, V., Bhatia, J., Saluja, D., & Srivastava, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101502 · Cited by 87
Sodium Intake and Vascular Stiffness in Hypertension
Safar, M. E., Temmar, M., Kakou, A., Lacolley, P., & Thornton, S. N. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.129585 · Cited by 83
Aldosterone Receptor Antagonism Normalizes Vascular Function in Liquorice-Induced Hypertension
Quaschning, T., Ruschitzka, F. T., Shaw, S., & Lüscher, T. F. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.801 · Cited by 84
Monogenic forms of hypertension
Simonetti, G. D., Mohaupt, M. G., & Bianchetti, M. G. (2011) · European Journal of Pediatrics · doi:10.1007/s00431-011-1440-7 · Cited by 82
Estrogen receptor variant and hypertension in women.
Lehrer, S. P., Rabin, J., Kalir, T., & Schachter, B. S. (1993) · Hypertension · doi:10.1161/01.hyp.21.4.439 · Cited by 82
Microdeletion and Microduplication Syndromes
Vissers, L. E. L. M., & Stankiewicz, P. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-507-7_2 · Cited by 98
Tsujita, Y., Iwai, N., Katsuya, T., Higaki, J., Ogihara, T., Tamaki, S., Kinoshita, M., Mannami, T., Ogata, J., & Baba, S. (2001) · Hypertension Research · doi:10.1291/hypres.24.105 · Cited by 84
Melander, O., Orho, M., Fagerudd, J. A., Bengtsson, K., Groop, P., Mattiasson, I., Groop, L., & Hulthén, U. L. (1998) · Hypertension · doi:10.1161/01.hyp.31.5.1118 · Cited by 83
Positive Association of Tyrosine Hydroxylase Microsatellite Marker to Essential Hypertension
Sharma, P., Hingorani, A., Jia, H., Ashby, M., Hopper, R., Clayton, D., & Brown, M. J. (1998) · Hypertension · doi:10.1161/01.hyp.32.4.676 · Cited by 80
Kumar, N. N., Benjafield, A., Lin, R. C. Y., Wang, W. Y. S., Stowasser, M., & Morris, B. J. (2003) · Journal of Hypertension · doi:10.1097/00004872-200307000-00022 · Cited by 89
Svensson-Färbom, P., Wahlstrand, B., Almgren, P., Dahlberg, J., Fava, C., Kjeldsen, S., Hedner, T., & Melander, O. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283410390 · Cited by 77
Dluhy, R. G., & Lifton, R. P. (1995) · Steroids · doi:10.1016/0039-128x(94)00010-a · Cited by 78
Self-citation
Metadata
- Authors
- Lifton, R. P., Dluhy, R. G., Powers, M., Rich, G. M., Cook, S., Ulick, S., & Lalouel, J.-M.
- Affiliations
- Howard Hughes Medical Institute (US)
- Brigham and Women's Hospital (US)
- Veterans Health Administration (US)
- ORCID
- Lifton, Richard P.
- Venue
- Nature
- Published
- 1992-01
- Volume
- 355
- Issue
- 6357
- Pages
- 262-265
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1979069430
- Semantic Scholar
- 48f7453ea9e77a6f893ab90603be6343f5cad138
- Cited by
- 1,158
- References
- 23
- Citations by year
- 2026: 18 · 2025: 10 · 2024: 21 · 2023: 37 · 2022: 29 · 2021: 26 · 2020: 25 · 2019: 24 · 2018: 36 · 2017: 35 · 2016: 30 · 2015: 34 · 2014: 34 · 2013: 36 · 2012: 32
- FWCI
- 30.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Keywords
- glucocorticoid-remediable aldosteronism, aldosterone synthase, 11β-hydroxylase, fusion genes, gene duplication, unequal crossover, hypertension, hyperaldosteronism, 18-oxocortisol, 18-hydroxycortisol, ACTH, chromosome 8q, genetic linkage, autosomal dominant disorder, adrenal glomerulosa
- MeSH terms
- Base Sequence, Chimera, Crossing Over, Genetic, Cytochrome P-450 Enzyme System, Exons, Female, Humans, Hyperaldosteronism, Hypertension, Introns, Male, Molecular Sequence Data, Oligodeoxyribonucleotides, Pedigree, Steroid Hydroxylases, Steroid 11-beta-Hydroxylase, Polymerase Chain Reaction, Cytochrome P-450 CYP11B2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.